Engineers Gate Manager LP Wave Life Sciences Ltd. Transaction History

Engineers Gate Manager LP

  • $5.55 Billion
  • Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Engineers Gate Manager LP holds 115,668 shares of WVE stock, worth $987,804. This represents 0.02% of its overall portfolio holdings.

Number of Shares
115,668
Previous 42,379 172.94%
Holding current value
$987,804
Previous $524,000 78.24%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$8.08 - $13.51 $592,175 - $990,134
73,289 Added 172.94%
115,668 $934,000
Q4 2024

Feb 14, 2025
BUY
$8.0 - $16.44 $153,208 - $314,842
19,151 Added 82.45%
42,379 $524,000
Q3 2024

Nov 14, 2024
SELL
$5.12 - $9.01 $239,836 - $422,055
-46,843 Reduced 66.85%
23,228 $190,000
Q2 2024

Aug 14, 2024
BUY
$4.38 - $6.48 $87,175 - $128,971
19,903 Added 39.67%
70,071 $349,000
Q1 2024

May 15, 2024
BUY
$3.54 - $6.84 $82,651 - $159,700
23,348 Added 87.05%
50,168 $309,000
Q4 2023

Feb 14, 2024
BUY
$4.16 - $6.87 $111,571 - $184,253
26,820 New
26,820 $135,000
Q2 2021

Aug 16, 2021
SELL
$5.65 - $7.47 $161,047 - $212,924
-28,504 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.61 - $12.01 $10,821 - $23,167
1,929 Added 7.26%
28,504 $160,000
Q4 2020

Feb 16, 2021
SELL
$6.99 - $9.26 $95,686 - $126,760
-13,689 Reduced 34.0%
26,575 $209,000
Q3 2020

Nov 16, 2020
BUY
$8.49 - $19.54 $341,841 - $786,758
40,264 New
40,264 $342,000
Q3 2019

Nov 14, 2019
SELL
$19.17 - $27.4 $170,938 - $244,325
-8,917 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$22.93 - $42.84 $204,466 - $382,004
8,917 New
8,917 $233,000

Others Institutions Holding WVE

# of Institutions
201
Shares Held
125M
Call Options Held
499K
Put Options Held
180K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $741M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email